MSD prevails in diabetes drug dispute with Mylan

29-09-2022

Muireann Bolger

MSD prevails in diabetes drug dispute with Mylan

Atmosphere1 / Shutterstock.com

MSD, known as Merck in the US and Canada, has won against a case concerning branded diabetes treatment Janumet XR at the US Court of Appeals for the Federal Circuit.


MSD, Mylan, PTAB, diabetes drug dispute, patent infringement

LSIPR